WHO ICTRP trial
Phase I/II trial of neoadjuvant intravenous gemcitabine plus intra-arterial…
JPRN-UMIN000013636 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000013636 |
|---|---|
| Public title | Phase I/II trial of neoadjuvant intravenous gemcitabine plus intra-arterial cisplatin in muscle-invasive bladder cancer. |
| Scientific title | Phase I/II trial of neoadjuvant intravenous gemcitabine plus intra-arterial cisplatin in muscle-invasive bladder cancer. - Phase I/II trial of neoadjuvant intravenous gemcitabine plus intra-arterial cisplatin in muscle-invasive bladder cancer. |
| Primary sponsor | Nippon Medical School Musashokosugi Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | bladder cancer |
| Interventions | level1 gemcitabine100mg/m2 IV day1,8,15 ciaplatin 70mg/m2 IA day2 q28days 3cycles level2 gemcitabine 100mg/m2 IV day1,8,15 ciaplatin 100mg/m2 IA day2 q28days 3cycles If feasibility of level1 treatment is confirmed, we go to level2. |
| Registration date | Apr 4, 2014 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: